EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three months ended March 31, 2007. The Company ended the first quarter with a net loss of $7.8 million, or $0.15 per share on total revenues of $6.4 million compared with net income of $4.0 million, or $0.06 per share on total revenues of $9.5 million for the same period in 2006. The company ended the quarter with $174.9 million in cash and investments.
